nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PPARG—urinary bladder cancer	0.519	0.703	CbGaD
Balsalazide—PTGS2—urinary bladder cancer	0.219	0.297	CbGaD
Balsalazide—PTGS2—Cisplatin—urinary bladder cancer	0.0525	0.356	CbGbCtD
Balsalazide—PTGS2—Etoposide—urinary bladder cancer	0.0516	0.349	CbGbCtD
Balsalazide—PTGS1—Etoposide—urinary bladder cancer	0.0436	0.295	CbGbCtD
Balsalazide—ALOX5—prostate gland—urinary bladder cancer	0.00306	0.0866	CbGeAlD
Balsalazide—PPARG—Teniposide—Etoposide—urinary bladder cancer	0.00286	1	CbGdCrCtD
Balsalazide—PPARG—prostate gland—urinary bladder cancer	0.0023	0.065	CbGeAlD
Balsalazide—ALOX5—smooth muscle tissue—urinary bladder cancer	0.00217	0.0613	CbGeAlD
Balsalazide—ALOX5—urethra—urinary bladder cancer	0.00205	0.058	CbGeAlD
Balsalazide—PPARG—epithelium—urinary bladder cancer	0.00169	0.0478	CbGeAlD
Balsalazide—ALOX5—female reproductive system—urinary bladder cancer	0.00167	0.0473	CbGeAlD
Balsalazide—PPARG—smooth muscle tissue—urinary bladder cancer	0.00163	0.046	CbGeAlD
Balsalazide—PPARG—renal system—urinary bladder cancer	0.00157	0.0443	CbGeAlD
Balsalazide—PPARG—urethra—urinary bladder cancer	0.00154	0.0435	CbGeAlD
Balsalazide—PPARG—female reproductive system—urinary bladder cancer	0.00126	0.0355	CbGeAlD
Balsalazide—Olsalazine—PPARG—urinary bladder cancer	0.00124	0.247	CrCbGaD
Balsalazide—PTGS1—prostate gland—urinary bladder cancer	0.00123	0.0347	CbGeAlD
Balsalazide—PTGS2—prostate gland—urinary bladder cancer	0.00118	0.0332	CbGeAlD
Balsalazide—PPARG—vagina—urinary bladder cancer	0.00114	0.0321	CbGeAlD
Balsalazide—PTGS1—seminal vesicle—urinary bladder cancer	0.00104	0.0294	CbGeAlD
Balsalazide—PTGS2—seminal vesicle—urinary bladder cancer	0.000994	0.0281	CbGeAlD
Balsalazide—ALOX5—lymph node—urinary bladder cancer	0.000978	0.0276	CbGeAlD
Balsalazide—PTGS1—epithelium—urinary bladder cancer	0.000904	0.0255	CbGeAlD
Balsalazide—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000871	0.0246	CbGeAlD
Balsalazide—Bezafibrate—PPARG—urinary bladder cancer	0.000866	0.172	CrCbGaD
Balsalazide—PTGS2—epithelium—urinary bladder cancer	0.000864	0.0244	CbGeAlD
Balsalazide—Sulfasalazine—PPARG—urinary bladder cancer	0.000858	0.171	CrCbGaD
Balsalazide—PTGS1—renal system—urinary bladder cancer	0.000838	0.0237	CbGeAlD
Balsalazide—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000832	0.0235	CbGeAlD
Balsalazide—PTGS2—renal system—urinary bladder cancer	0.000801	0.0226	CbGeAlD
Balsalazide—PTGS2—urethra—urinary bladder cancer	0.000787	0.0222	CbGeAlD
Balsalazide—PPARG—lymph node—urinary bladder cancer	0.000734	0.0208	CbGeAlD
Balsalazide—PTGS1—female reproductive system—urinary bladder cancer	0.000671	0.019	CbGeAlD
Balsalazide—Bromfenac—PTGS2—urinary bladder cancer	0.000661	0.132	CrCbGaD
Balsalazide—PTGS2—female reproductive system—urinary bladder cancer	0.000642	0.0181	CbGeAlD
Balsalazide—PTGS1—vagina—urinary bladder cancer	0.000607	0.0172	CbGeAlD
Balsalazide—PTGS2—vagina—urinary bladder cancer	0.00058	0.0164	CbGeAlD
Balsalazide—Olsalazine—PTGS2—urinary bladder cancer	0.000523	0.104	CrCbGaD
Balsalazide—Fenbufen—PTGS2—urinary bladder cancer	0.000512	0.102	CrCbGaD
Balsalazide—PTGS1—lymph node—urinary bladder cancer	0.000393	0.0111	CbGeAlD
Balsalazide—PTGS2—lymph node—urinary bladder cancer	0.000375	0.0106	CbGeAlD
Balsalazide—Sulfasalazine—PTGS2—urinary bladder cancer	0.000362	0.0722	CrCbGaD
Balsalazide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000148	0.00209	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP4B1—urinary bladder cancer	0.000146	0.00207	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000146	0.00207	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000144	0.00204	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000143	0.00203	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000142	0.00202	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000142	0.00201	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—SLC19A1—urinary bladder cancer	0.000138	0.00195	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—FAS—urinary bladder cancer	0.000138	0.00195	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000137	0.00194	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—TNF—urinary bladder cancer	0.000136	0.00192	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000136	0.00192	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PRSS3—urinary bladder cancer	0.000135	0.0019	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000133	0.00188	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.00013	0.00184	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000127	0.00179	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.000126	0.00178	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000122	0.00172	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000121	0.00171	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000118	0.00167	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000117	0.00166	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—EP300—urinary bladder cancer	0.000117	0.00165	CbGpPWpGaD
Balsalazide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000116	0.00164	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTZ1—urinary bladder cancer	0.000116	0.00164	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000116	0.00163	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000115	0.00163	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000114	0.00162	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000114	0.00161	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000113	0.0016	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000111	0.00157	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTO2—urinary bladder cancer	0.00011	0.00156	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NAT1—urinary bladder cancer	0.00011	0.00156	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000108	0.00153	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000108	0.00153	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TYMP—urinary bladder cancer	0.000108	0.00152	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—CDKN1A—urinary bladder cancer	0.000107	0.00152	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000106	0.0015	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000105	0.00148	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000104	0.00146	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000103	0.00146	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.000103	0.00146	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000103	0.00146	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—UGT2B7—urinary bladder cancer	0.000101	0.00142	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	9.9e-05	0.0014	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NAT2—urinary bladder cancer	9.73e-05	0.00138	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	9.17e-05	0.0013	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP4B1—urinary bladder cancer	9.06e-05	0.00128	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9e-05	0.00127	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	8.97e-05	0.00127	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.92e-05	0.00126	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	8.75e-05	0.00124	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—SLC19A1—urinary bladder cancer	8.55e-05	0.00121	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	8.46e-05	0.0012	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—RRM2—urinary bladder cancer	8.4e-05	0.00119	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PRSS3—urinary bladder cancer	8.33e-05	0.00118	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TNF—urinary bladder cancer	8.29e-05	0.00117	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	8.15e-05	0.00115	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	8.13e-05	0.00115	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	8.05e-05	0.00114	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.98e-05	0.00113	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	7.95e-05	0.00112	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.93e-05	0.00112	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	7.87e-05	0.00111	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—HPGDS—urinary bladder cancer	7.78e-05	0.0011	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ENO2—urinary bladder cancer	7.78e-05	0.0011	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.74e-05	0.00109	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTO2—urinary bladder cancer	7.7e-05	0.00109	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NAT1—urinary bladder cancer	7.7e-05	0.00109	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.58e-05	0.00107	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—PTEN—urinary bladder cancer	7.55e-05	0.00107	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GSTT1—urinary bladder cancer	7.55e-05	0.00107	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—NCOR1—urinary bladder cancer	7.48e-05	0.00106	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.43e-05	0.00105	CbGpPWpGaD
Balsalazide—PTGS2—Disease—GSTO2—urinary bladder cancer	7.3e-05	0.00103	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—EP300—urinary bladder cancer	7.2e-05	0.00102	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	7.15e-05	0.00101	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.05e-05	0.000997	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	7.05e-05	0.000997	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.02e-05	0.000993	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	7.01e-05	0.000992	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.99e-05	0.000989	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	6.84e-05	0.000967	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.68e-05	0.000945	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	6.66e-05	0.000943	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TYMP—urinary bladder cancer	6.66e-05	0.000943	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	6.48e-05	0.000917	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	6.47e-05	0.000915	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	6.45e-05	0.000913	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.4e-05	0.000905	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	6.34e-05	0.000897	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.3e-05	0.000891	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NQO1—urinary bladder cancer	6.27e-05	0.000887	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ESR1—urinary bladder cancer	6.24e-05	0.000883	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.13e-05	0.000867	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTO2—urinary bladder cancer	6.12e-05	0.000865	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NAT1—urinary bladder cancer	6.12e-05	0.000865	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.09e-05	0.000861	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.05e-05	0.000856	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NAT2—urinary bladder cancer	6.03e-05	0.000852	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.01e-05	0.000851	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.99e-05	0.000848	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CDK4—urinary bladder cancer	5.9e-05	0.000835	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.84e-05	0.000826	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—SMC1A—urinary bladder cancer	5.69e-05	0.000805	CbGpPWpGaD
Balsalazide—PTGS2—Disease—SLC19A1—urinary bladder cancer	5.68e-05	0.000803	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	5.59e-05	0.000791	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PRSS3—urinary bladder cancer	5.53e-05	0.000783	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	5.51e-05	0.000779	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.47e-05	0.000774	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	5.34e-05	0.000756	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.31e-05	0.000751	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HDAC4—urinary bladder cancer	5.28e-05	0.000747	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GSTP1—urinary bladder cancer	5.23e-05	0.00074	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	5.23e-05	0.00074	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—RRM2—urinary bladder cancer	5.2e-05	0.000736	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—TP53—urinary bladder cancer	5.15e-05	0.000729	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CREBBP—urinary bladder cancer	5.15e-05	0.000729	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.13e-05	0.000726	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.06e-05	0.000716	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	5.04e-05	0.000712	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.98e-05	0.000704	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ESR2—urinary bladder cancer	4.96e-05	0.000701	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TYMS—urinary bladder cancer	4.86e-05	0.000688	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—HPGDS—urinary bladder cancer	4.82e-05	0.000681	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ENO2—urinary bladder cancer	4.82e-05	0.000681	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GSTM1—urinary bladder cancer	4.81e-05	0.00068	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NCOR1—urinary bladder cancer	4.81e-05	0.00068	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.76e-05	0.000673	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.68e-05	0.000662	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTT1—urinary bladder cancer	4.67e-05	0.000661	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.67e-05	0.00066	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—RHOA—urinary bladder cancer	4.66e-05	0.000659	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4.63e-05	0.000656	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GPX1—urinary bladder cancer	4.6e-05	0.000651	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.6e-05	0.000651	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.53e-05	0.000641	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ERCC2—urinary bladder cancer	4.52e-05	0.000639	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.48e-05	0.000634	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	4.39e-05	0.000621	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.39e-05	0.00062	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.38e-05	0.000619	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—ERBB2—urinary bladder cancer	4.31e-05	0.00061	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—MTHFR—urinary bladder cancer	4.25e-05	0.000601	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.22e-05	0.000597	CbGpPWpGaD
Balsalazide—PTGS2—Disease—LIG1—urinary bladder cancer	4.19e-05	0.000593	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.17e-05	0.00059	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.06e-05	0.000574	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NQO1—urinary bladder cancer	3.88e-05	0.000549	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—NCOR1—urinary bladder cancer	3.83e-05	0.000541	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.77e-05	0.000533	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.72e-05	0.000526	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.71e-05	0.000524	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP9—urinary bladder cancer	3.7e-05	0.000523	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.64e-05	0.000515	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.64e-05	0.000514	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ERCC2—urinary bladder cancer	3.6e-05	0.000509	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.56e-05	0.000503	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.56e-05	0.000503	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—EP300—urinary bladder cancer	3.51e-05	0.000496	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PPARG—urinary bladder cancer	3.45e-05	0.000487	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—SRC—urinary bladder cancer	3.41e-05	0.000483	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.39e-05	0.000479	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.37e-05	0.000477	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.37e-05	0.000477	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.36e-05	0.000475	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.35e-05	0.000475	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.35e-05	0.000474	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CREBBP—urinary bladder cancer	3.31e-05	0.000468	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.29e-05	0.000465	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.27e-05	0.000463	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—MYC—urinary bladder cancer	3.25e-05	0.000459	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTP1—urinary bladder cancer	3.24e-05	0.000458	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.22e-05	0.000456	CbGpPWpGaD
Balsalazide—PTGS2—Disease—ENO2—urinary bladder cancer	3.2e-05	0.000453	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.13e-05	0.000443	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RBX1—urinary bladder cancer	3.03e-05	0.000429	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TYMS—urinary bladder cancer	3.01e-05	0.000426	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ESR1—urinary bladder cancer	3.01e-05	0.000425	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—EGFR—urinary bladder cancer	2.99e-05	0.000423	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.99e-05	0.000422	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NCOR1—urinary bladder cancer	2.98e-05	0.000421	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTM1—urinary bladder cancer	2.98e-05	0.000421	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.89e-05	0.000409	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GPX1—urinary bladder cancer	2.85e-05	0.000403	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TNF—urinary bladder cancer	2.85e-05	0.000403	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—KRAS—urinary bladder cancer	2.82e-05	0.0004	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ERCC2—urinary bladder cancer	2.8e-05	0.000396	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.72e-05	0.000385	CbGpPWpGaD
Balsalazide—PTGS2—Disease—JAG1—urinary bladder cancer	2.71e-05	0.000384	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PTGS2—urinary bladder cancer	2.71e-05	0.000383	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.68e-05	0.000379	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.68e-05	0.000379	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.66e-05	0.000377	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.64e-05	0.000373	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—CREBBP—urinary bladder cancer	2.63e-05	0.000373	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—MTHFR—urinary bladder cancer	2.63e-05	0.000372	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.6e-05	0.000368	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.56e-05	0.000362	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—HRAS—urinary bladder cancer	2.4e-05	0.00034	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PTEN—urinary bladder cancer	2.36e-05	0.000334	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.3e-05	0.000326	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.27e-05	0.000321	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—EP300—urinary bladder cancer	2.25e-05	0.000319	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.19e-05	0.000311	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.16e-05	0.000305	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.11e-05	0.000298	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.08e-05	0.000295	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.08e-05	0.000295	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CREBBP—urinary bladder cancer	2.05e-05	0.00029	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GPX1—urinary bladder cancer	2e-05	0.000282	CbGpPWpGaD
Balsalazide—PTGS2—Disease—NCOR1—urinary bladder cancer	1.98e-05	0.00028	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.96e-05	0.000277	CbGpPWpGaD
Balsalazide—PTGS2—Disease—ERCC2—urinary bladder cancer	1.86e-05	0.000263	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.84e-05	0.000261	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.83e-05	0.000258	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.8e-05	0.000255	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MTHFR—urinary bladder cancer	1.75e-05	0.000247	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.74e-05	0.000246	CbGpPWpGaD
Balsalazide—PTGS2—Disease—TERT—urinary bladder cancer	1.74e-05	0.000246	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PTGS2—urinary bladder cancer	1.68e-05	0.000237	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.67e-05	0.000237	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.65e-05	0.000234	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.65e-05	0.000234	CbGpPWpGaD
Balsalazide—PTGS2—Disease—FGFR3—urinary bladder cancer	1.6e-05	0.000226	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.58e-05	0.000224	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—MYC—urinary bladder cancer	1.56e-05	0.000221	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.56e-05	0.00022	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.49e-05	0.000211	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PTEN—urinary bladder cancer	1.46e-05	0.000207	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.46e-05	0.000207	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.000203	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—EP300—urinary bladder cancer	1.4e-05	0.000197	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CREBBP—urinary bladder cancer	1.36e-05	0.000192	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RHOA—urinary bladder cancer	1.23e-05	0.000174	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.19e-05	0.000168	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000166	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	0.000161	CbGpPWpGaD
Balsalazide—PTGS2—Disease—ERBB2—urinary bladder cancer	1.14e-05	0.000161	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.02e-05	0.000145	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—EP300—urinary bladder cancer	9.77e-06	0.000138	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CDKN1A—urinary bladder cancer	9.74e-06	0.000138	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PTEN—urinary bladder cancer	9.72e-06	0.000137	CbGpPWpGaD
Balsalazide—PTGS2—Disease—EP300—urinary bladder cancer	9.27e-06	0.000131	CbGpPWpGaD
Balsalazide—PTGS2—Disease—SRC—urinary bladder cancer	9.01e-06	0.000127	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PTEN—urinary bladder cancer	8.14e-06	0.000115	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MYC—urinary bladder cancer	8.07e-06	0.000114	CbGpPWpGaD
Balsalazide—PTGS2—Disease—EGFR—urinary bladder cancer	7.9e-06	0.000112	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—EP300—urinary bladder cancer	7.76e-06	0.00011	CbGpPWpGaD
Balsalazide—PTGS2—Disease—KRAS—urinary bladder cancer	7.46e-06	0.000106	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HRAS—urinary bladder cancer	6.34e-06	8.97e-05	CbGpPWpGaD
